⚠
✓
Mesoblast Ltd.
Mesoblast Ltd.
Level 38, 55 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
(03) 9639 6036
Sector: Healthcare
Description
ASX-listed, Melbourne headquartered health care player Mesoblast Limited (ASX:MSB) is a frontrunner in developing innovative cellular medicines across the globe. MSB has a strong emerging drug pipeline with its three programs currently under phase III clinical studies. The lead drug candidates of Mesoblast remestemcel-L, revascor, MPC-300-IV and MPC-06-ID are under clinical development. The Company has a robust and broad worldwide intellectual property portfolio with protection extending through to at least 2040 in all main markets.Peers

OCA
Oceania Healthcare Limited

NVAX
Novavax Inc

AFT
AFT Pharmaceuticals Limited

ANP
Antisense Therapeutics Ltd.

PTX
Prescient Therapeutics Limited

MRNA
Moderna Inc

CVT
Comvita Limited

PEB
Pacific Edge Limited

NOX
Noxopharm Limited

IMU
Imugene Limited

SKN
Skin Elements Ltd

ORPH
Open Orphan Plc
Related Articles
Loading...